Category: Patent Added

April 10, 2019Comments Off on New patent for Amgen Inc drug CORLANOR Posted in: Patent Added

Annual Drug Patent Expirations for CORLANOR Corlanor is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are four patents… The post New patent for Amgen Inc drug CORLANOR appeared first on DrugPatentWatc…

April 10, 2019Comments Off on New patent for Tetraphase Pharms drug XERAVA Posted in: Patent Added

Annual Drug Patent Expirations for XERAVA Xerava is a drug marketed by Tetraphase Pharms and is included in one NDA. It is available from one supplier. The generic ingredient in… The post New patent for Tetraphase Pharms drug XERAVA appeared first on D…

April 10, 2019Comments Off on New patent for Corcept Therap drug KORLYM Posted in: Patent Added

Annual Drug Patent Expirations for KORLYM Korlym is a drug marketed by Corcept Therap and is included in one NDA. It is available from one supplier. There are eight patents… The post New patent for Corcept Therap drug KORLYM appeared first on DrugPaten…

April 10, 2019Comments Off on New patent for Kowa Co drug LIVALO Posted in: Patent Added

Annual Drug Patent Expirations for LIVALO Livalo is a drug marketed by Kowa Co and is included in one NDA. It is available from one supplier. There are three patents… The post New patent for Kowa Co drug LIVALO appeared first on DrugPatentWatch – Make …

Annual Drug Patent Expirations for PROMACTA+KIT Promacta Kit is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are… The post New patent for Novartis Pharms drug PROMACTA KIT appeared first o…

April 10, 2019Comments Off on New patent for Alkermes Inc drug ARISTADA Posted in: Patent Added

Annual Drug Patent Expirations for ARISTADA Aristada is a drug marketed by Alkermes Inc and is included in two NDAs. It is available from one supplier. There are eight patents… The post New patent for Alkermes Inc drug ARISTADA appeared first on DrugPa…

April 10, 2019Comments Off on New patent for Astellas drug LEXISCAN Posted in: Patent Added

Annual Drug Patent Expirations for LEXISCAN Lexiscan is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are seventeen patents protecting… The post New patent for Astellas drug LEXISCAN appeared first on …

April 10, 2019Comments Off on New patent for Janssen Prods drug PREZISTA Posted in: Patent Added

Annual Drug Patent Expirations for PREZISTA Prezista is a drug marketed by Janssen Prods and is included in two NDAs. It is available from four suppliers. There are five patents… The post New patent for Janssen Prods drug PREZISTA appeared first on Dru…

April 3, 2019Comments Off on New patent for Jazz Pharms drug XYREM Posted in: Patent Added

Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from one supplier. There are eighteen patents… The post New patent for Jazz Pharms drug XYREM appeared first on DrugPatentWatch…

April 3, 2019Comments Off on New patent for Helsinn Hlthcare drug AKYNZEO Posted in: Patent Added

Annual Drug Patent Expirations for AKYNZEO Akynzeo is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from one supplier. There are eleven patents… The post New patent for Helsinn Hlthcare drug AKYNZEO appeared first on …